Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive impairment after cytotoxic chemotherapy
Petra Huehnchen, Antonia van Kampen, Wolfgang Boehmerle, et al.
Neuro-Oncology Practice (2019) Vol. 7, Iss. 1, pp. 11-21
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Frailty and Cancer: Current Perspectives on Assessment and Monitoring
Valentin Goede
Clinical Interventions in Aging (2023) Vol. Volume 18, pp. 505-521
Open Access | Times Cited: 76
Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy
Qianqian Mao, Juan Min, Rui Zeng, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6088-6105
Open Access | Times Cited: 53
Traditional Chinese medicine polysaccharide in nano-drug delivery systems: Current progress and future perspectives
Juan Wang, Xia Wu, Jing Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116330-116330
Open Access | Times Cited: 15
Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care
Judith Carroll, Julienne E. Bower, Patricia A. Ganz
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 173-187
Open Access | Times Cited: 55
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam, Joanne M. Bowen, Marc A. Gladman, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 470-479
Open Access | Times Cited: 40
Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
Eiman Ibrahim, Ilaria Domenicano, Kate Nyhan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 38
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Sheng Yu, Wen Li, Lingxue Tang, et al.
Cancer Letters (2022) Vol. 536, pp. 215648-215648
Closed Access | Times Cited: 23
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Allicin mitigates hepatic injury following cyclophosphamide administration via activation of Nrf2/ARE pathways and through inhibition of inflammatory and apoptotic machinery
Dongsheng Sun, Chen Sun, Gongcai Qiu, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 39625-39636
Closed Access | Times Cited: 28
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
The Clinical Frailty Scale as useful tool in patients with brain metastases
Johannes Kerschbaumer, Aleksandrs Krigers, Matthias Demetz, et al.
Journal of Neuro-Oncology (2022) Vol. 158, Iss. 1, pp. 51-57
Open Access | Times Cited: 16
Modeling neurotoxin-induced neuroinflammation with chemotherapy
Mai F. Tolba, Nada K. Sedky, Marwa A. Ali, et al.
Elsevier eBooks (2022), pp. 403-417
Closed Access | Times Cited: 14
Predictors of cognitive impairment in patients undergoing ileostomy for colorectal cancer: a retrospective analysis
Jing Xu, Yuelan Yang, Die Hu
PeerJ (2023) Vol. 11, pp. e15405-e15405
Open Access | Times Cited: 7
Feasibility study of a multimodal prehabilitation programme in women receiving neoadjuvant therapy for breast cancer in a major cancer hospital: a protocol
Suzanne Grant, Shelley Kay, Judith Lacey, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e080239-e080239
Open Access | Times Cited: 2
Functioning of autobiographical memory specificity and self-defining memories in people with cancer diagnosis
Marta Nieto, Beatriz Navarro Bravo, Beatriz Moreno, et al.
PeerJ (2019) Vol. 7, pp. e8126-e8126
Open Access | Times Cited: 15
The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2−/+ Breast Cancer
Wen Li, Qianqian Zhang, Yinlian Cai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Subgroups of patients undergoing chemotherapy with distinct cognitive fatigue and evening physical fatigue profiles
Lisa Morse, Kord M. Kober, Carol Viele, et al.
Supportive Care in Cancer (2021) Vol. 29, Iss. 12, pp. 7985-7998
Closed Access | Times Cited: 11
Epirubicin Treatment Induces Neurobehavioral, Oxido-Inflammatory and Neurohistology Alterations in Rats: Protective Effect of the Endogenous Metabolite of Tryptophan − 3-Indolepropionic Acid
Solomon E. Owumi, Grace Adebisi
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2767-2783
Closed Access | Times Cited: 4
Utility of zebrafish-based models in understanding molecular mechanisms of neurotoxicity mediated by the gut–brain axis
Isaac A. Adedara, Khadija A. Mohammed, Júlia Canzian, et al.
Advances in neurotoxicology (2024), pp. 177-209
Closed Access | Times Cited: 1
Chemotherapy-Induced Changes in Plasma Amino Acids and Lipid Oxidation of Resected Patients with Colorectal Cancer: A Background for Future Studies
Roberto Aquilani, Silvia Brugnatelli, Roberto Maestri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5300-5300
Open Access | Times Cited: 1
The Protective Effect of Bergamot Polyphenolic Fraction (BPF) on Chemotherapy-Induced Neuropathic Pain
Sara Ilari, Filomena Lauro, Luigino Antonio Giancotti, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 975-975
Open Access | Times Cited: 10
Active targeting nano-scale bubbles enhanced ultrasound cavitation chemotherapy in Y1 receptor-overexpressed breast cancer
Xuechen Qian, Yinjie Wang, Youfeng Xu, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 31, pp. 6837-6844
Closed Access | Times Cited: 10
The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients
Sheng Yu, Jingjing Zhao, Menglian Wang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Anti-Cancer Effects of a New Herbal Medicine PSY by Inhibiting the STAT3 Signaling Pathway in Colorectal Cancer Cells and Its Phytochemical Analysis
Sanghee Han, Hail Kim, Min Young Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14826-14826
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top